Search Results

The GORE® ACUSEAL Vascular Graft is intended for use as a vascular prosthesis in patients requiring vascular access.

The GORE® ACUSEAL Vascular Graft is a synthetic graft made of an expanded polytetrafluoroethylene (ePTFE) tube with a reinforcing film for radial strength. The luminal surface of the vascular graft is coated with the CBAS® Heparin Surface.

The provided document is a 510(k) clearance letter from the FDA for a medical device called the GORE® ACUSEAL Vascular Graft. This type of document establishes substantial equivalence to a predicate device and does not contain the detailed study information typically found in a clinical trial report or an academic paper describing device performance against explicit acceptance criteria.

Specifically, the document states:

• "One in vitro study was conducted to demonstrate substantial equivalence to the predicate device."
• "The GORE® ACUSEAL Vascular Graft is substantially equivalent to the predicate device. The change to the end-of-shelf-life Heparin Surface Activity specification does not raise new types of safety or effectiveness questions, and the testing provided in this application supports a determination of substantial equivalence."

Therefore, the document does not provide the information requested regarding acceptance criteria and the detailed study that proves the device meets them because it's a 510(k) clearance based on substantial equivalence, not a performance study against predefined criteria.

The 510(k) process focuses on demonstrating that a new device is as safe and effective as a legally marketed predicate device, rather than proving performance against specific quantitative acceptance criteria or conducting extensive clinical trials, especially for Class II devices like this vascular graft.

As a result, I cannot fill in the requested table and details about the study because that information is not present in the provided FDA clearance letter.

Ask a specific question about this device